Three biomolecules proposed as biomarkers for differentiating between diffuse and limited systemic sclerosis are produced by progenitor myelopoietic cells (SuPAR), the muscle of the left atrium of the heart (MR-proANP), and macrophages (GDF-15). This evidence concerns the gene GDF15 and limited cutaneous systemic sclerosis.